Studie možných vlivů pohlaví na léčbu ramiprilem a candesartanem při experimentální arteriální hypertenzi u potkanů

1. Regitz-Zagrosek V., Kararigas G. Mechanistic pathways of sex differences in cardiovascular disease. Physiol. Rev. 2017; 97(1), 1–37. https://doi.org/10.1152/physrev. 00021.2015

2. Marques A. P., Szwarcwald C. L., Pires D. C., Rodrigues J. M., Almeida W. D. S., Romero D. Factors associated with arterial hypertension: a systematic review. Cien Saude Colet. 2020; 25(6), 2271–2282. Portuguese. doi: https://doi.org/10.1590/1413-81232020256.26972018

3. Eric D. A. Sex hormones across the menstrual cycle in pulmonary arterial hypertension: adding a new layer of complexity. Ann. Am. Thorac. Soc. 2021; 18(2), 209–211. https://doi.org/10.1513/AnnalsATS.202011-1379ED

4. Tang C., Luo Y., Li S., Huang B., Xu S., Li L. Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats. Biomed. Pharmacother. 2021; 133, 111081. https://doi.org/10.1016/j. biopha.2020.111081

5. Zimmerman M. A., Budish R. A., Kashyap S., Lindsey S. H. GPER-novel membrane oestrogen receptor. Clin. Sci. 2016; 130(12), 1005–1016. https://doi.org/10.1042/ CS20160114

6. Hester J., Ventetuolo C., Lahm T. Sex, gender, and sex hormones in pulmonary hypertension and right ventricular failure. Compr. Physiol. 2020; 10(1), 125–170. https:// doi.org/10.1002/cphy.c190011

7. DuPont J. J., Kenney R. M., Patel A. R., Jaffe I. Z. Sex differences in mechanisms of arterial stiffness. Br. J. Pharmacol. 2019;176(21), 4208–4225. https://doi.org/10.1111 /bph.14624

8. Ge X., Zhu T., Zhang X., Liu Y., Wang Y., Zhang W. Gender differences in pulmonary arterial hypertension patients with BMPR2 mutation: a meta-analysis. Respir. Res. 2020; 21(1), 44. https://doi.org/10.1186/s12931-020- 1309-2

9. Agarwala A., Michos E. D., Samad Z., Ballantyne C. M., Virani S. S. The use of sex-specific factors in the assessment of women’s cardiovascular risk. Circulation 2020; 141(7), 592–599. https://doi.org/10.1161/CIRCULATIONAHA. 119.043429

10. Ojji D., Mayosi B., Francis V., Badri M., et al. for the CREOLE Study Investigators. Comparison of dual therapies for lowering blood pressure in black Africans. N. Engl. J. Med. 2019; 380, 2429–2439. https://doi.org/10.1056/NEJMoa1901113

11. Costa E. C., Hay J. L., Kehler D. S., Boreskie K. F. Effects of high-intensity interval training versus moderate-intensity continuous training on blood pressure in adults with pre-to established hypertension: a systematic review and meta-analysis of randomized trials. Sports Med. 2018; 48, 2127–2142.

12. Stefanova O. V. Preclinical drug studies. Guideline. Kyiv: Avicenna 2001.

13. Reznikov O. G. General ethical principles of animal experiments. Endocrinology 2003; 8(1), 142–145.

14. AnalystSoft Inc., StatPlus – program pro statistickou analýzu. Verze 6. Režim elektronického přístupu, www. analystsoft.com

15. Skibitsky V. V, Gorodetskaya E. V., Fendrikova A. V., Kudryashov E. A. Gender features of combined antihypertensive therapy in patients with hypertension and coronary heart disease. Cardiovasc. Ther. Prevent. 2014; 13 (5), 14–21.

16. Denton K. M., Hilliard L. M., Tare М. Sex-related differences in hypertension: seek and ye shall find. Hypertension 2013; 62, 674–677.